Crh Medical

CRH Medical Corp. engages in the provision of gastroenterologists with services and products for the treatment of gastrointestinal diseases. It operates through the following business segments: Anesthesia Services, Product Sales, and Other. It also offers the CRH O'Regan System, which focuses on physician education, patient outcomes, and patient awareness. The Other segment covers the corporate activities. The company was founded in 2000 and is headquartered in Vancouver, Canada.

CRH Medical Corp.'s securityholders approved the acquisition of CRH by a subsidiary of WELL Health at the special meeting of CRH securityholders on Friday April 16, 2021. The transaction is expected to be completed on or about April 22, 2021 and represents WELL's largest acquisition to date with a total transaction value of approximately US$369.2 million.

WELL Health Provides an Update on its Proposed Acquisition of CRH Medical

VANCOUVER, BC, April 16, 2021 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE: CRHM) ("CRH" or the "Company") today announced that its securityholders approved the acquisition of CRH by a subsidiary of WELL Health Technologies Corp. ("WELL Health") at the special meeting of CRH securityholders today. The special resolution approving the arrangement was approved by: (i) 97.30% of the votes cast by CRH shareholders present in person or represented by proxy at the meeting; (ii) 97.49% of the votes cast by CRH shareholders, share unitholders and optionholders voting as a single class present in person or represented by proxy at the meeting; and (iii) 97.27% of the votes cast by "minority" CRH shareholders in accordance with Part 8 of Multilateral Instrument 61-101 – Protection of Minority Securityholders in Special Transactions.

CRH Medical Securityholders Approve Acquisition by WELL Health

VANCOUVER, BC, April 7, 2021 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE American: CRHM) ("CRH" or the "Company") announced today that it has filed with the U.S. Securities and Exchange Commission (the "SEC") a Current Report on Form 8-K containing certain disclosures that are intended to amend and supplement the Company's proxy statement and management information circular, dated March 19, 2021 (the "Circular"), relating to the special meeting of CRH securityholders that will be held in connection with the proposed acquisition of CRH by WELL Health Technologies Corp. (the "Arrangement"), which Circular was previously mailed to securityholders. The Current Report and supplemental disclosures are available on the SEC's website at http://www.sec.gov, on SEDAR at www.sedar.com and on the Company's website at http://investors.crhsystem.com.

CRH Medical Corporation Updates Special Meeting Materials in Connection with Proposed Arrangement with Well Health Technologies Corp.

VANCOUVER, BC, March 25, 2021 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE American: CRHM) ("CRH" or the "Company") announced today that it has mailed materials to the shareholders (the "Shareholders") optionholders and share unit holders of CRH, including the proxy statement and management information circular of the Company dated March 19, 2021 (the "Circular"), for the special meeting of CRH securityholders (the "Meeting") to be held on April 16, 2021 in connection with the proposed acquisition by WELL Health Technologies Corp. ("WELL") of all of the issued and outstanding common shares of the Company ("CRH Shares") pursuant to a plan of arrangement to be approved by the Supreme Court of British Columbia in accordance with Section 288 of the Business Corporations Act (British Columbia) (the "Arrangement"), previously announced on February 8 , 2021. Materials for the Meeting, including the Circular, are available on the SEC's website at http://www.sec.gov, on SEDAR at www.sedar.com and on the Company's website at http://investors.crhsystem.com.

CRH Medical Corporation Mails Special Meeting Materials in Connection with Proposed Arrangement with Well Health Technologies Corp.

VANCOUVER, BC, March 16, 2021 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ("CRH" or the "Company"), today announced financial and operating results for the year and three months ended December 31, 2020. Fourth quarter 2020 highlights (all results expressed in USD): Total revenue of $36.8 million, an increase of 21% from fourth quarter 2019 Anesthesia services revenue of $34.1 million, an increase of 24% from fourth quarter 2019 Anesthesia patient cases of 108,681 increased 15% from fourth quarter 2019 Adjusted operating EBITDA of $16.1 million, a 44% adjusted operating EBITDA margin Adjusted operating shareholder EBITDA of $11.2 million, an increase of 27% from fourth quarter 2019 Year-end highlights (all results expressed in USD) – Q1 to Q3 significantly impacted by COVID 19: Total revenue of $106.2 million, a decrease of 12% over 2019 Anesthesia services revenue of $97.7 million, a decrease of 11% over 2019 Anesthesia patient cases of 323,644, a decrease of 6% over 2019 Adjusted operating EBITDA of $42.4 million, a 40% adjusted operating EBITDA margin Adjusted operating shareholder EBITDA of $28.7 million, a decrease of 22% from 2019 Tushar Ramani, Chief Executive Officer of CRH, commented: "We are pleased to report record fourth quarter revenue and shareholder EBITDA as the impact of  COVID-19  on the facilities we serve has abated and they have returned to and remained at normal operating levels, yielding healthy organic growth in anesthesia case volumes and strong acquisition activity in the latter half of 2020.

CRH Medical Corporation Announces 2020 Fourth Quarter and Year-end Results

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of CRH Medical Corporation (NYSE: CRHM) to Well Health Technologies Corp. Under the terms of the proposed transaction, shareholders of CRH will receive only $4.00 in cash for each share of CRH that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whe

CRH MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CRH Medical Corporation - CRHM

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether CRH Medical Corporation (NYSE: CRHM) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of CRH Medical to Well Health Technologies Corp. for $4.00 per share. On behalf of CRH Medical shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures a

CRHM Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of CRH Medical Corporation Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – CRHM

NEW YORK, Feb. 8, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CRH Medical Corporation ("CRHM" or the "Company") (NYSE: CRHM) in connection with the proposed acquisition of the Company by...

SHAREHOLDER ALERT: WeissLaw LLP Investigates CRH Medical Corporation

CRH Medical (CRHM) stock is on the rise Monday after announcing a deal with Well Health and IP has everything investors need to know. The post CRHM Stock: 14 Things to Know About CRH Medical as Well Health Deal Catapults Shares appeared first on InvestorPlace.

CRHM Stock: 14 Things to Know About CRH Medical as Well Health Deal Catapults Shares

The stock price of CRH Medical Corp (NYSEAMERICAN: CRHM) is trading at over 80% pre-market. This is why it happened.

CRHM Stock Price Increases Over $80% Pre-Market: Why It Happened

CRH Medical Corp (NYSE: CRHM) shares triple in premarket on the heels of a definitive agreement with Well Health Technologies Corp, wherein WELL Health will acquire CRH Medical for the purchase price of approximately $292.7 million and a transaction value of roughly $369.2 million inclusive of credit facility. The purchase price of $4.00 per share represents a premium of approximately 83% to CRHM closing price on Feb. 5.

Well Health Scoops Up CRH Medical For $4 Per Share; CRHM Shares Skyrocket

VANCOUVER, Feb. 8, 2021 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE: CRHM) ("CRH" or the "Company") today announced that it has signed a definitive agreement (the "Acquisition Agreement") with Well Health Technologies Corp. ("WELL Health" or "WELL"), pursuant to which WELL...

CRH Medical Announces Agreement to be Acquired by Well Health

Amphastar Pharma

Evoqua Water Technologies

Barings BDC Inc

Biohaven Pharmaceutical Hld

Colfax

Global Blood Therapeutics

Hannon Armstrong Sustainable Infrastructure Capital

Houghton Mifflin Harcourt

Lexicon Pharmaceuticals

MannKind

Nektar Therapeutics

Nano-X Imaging

ObsEva

Personalis Inc

PIMCO Corporate & Income Opportunity Fund

Construction Partners

Surgery Partners

SP Plus

Takeda Pharmaceutical

Cohen & Steers Infrastructure Fund Inc

Xerium Technologies

A recap for my 20/20 Vision is offered for my readers. I will share my concerns about the current market conditions.

Final Update For My 20/20 Vision For 2020 Dividend Paying Stocks

CRH Medical Corp. (AMEX:CRHM) is a Canadian healthcare professional services company whose primary business is rolling up the gastroenterology anesthesia space in the United States.

CRH Medical - Don't Be Seduced by the Free Cash Flow

CRH Medical (CRHM) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

CRH Medical (CRHM) Surges: Stock Moves 5.8% Higher

CRH Medical Corp (CRHM) CEO Tushar Ramani on Q3 2020 Results - Earnings Call Transcript

CRH Medical Corporation Common Shares of Beneficial Interest (AMEX: CRHM) unveils its next round of earnings this Thursday, November 12. Here is Benzinga's everything-that-matters guide for the earnings announcement.

Preview: CRH Medical Corporation Common Shares of Beneficial Interest's Earnings

CRH Medical (CRHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: CRH Medical (CRHM) Q3 Earnings Expected to Decline

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy CRH Medical (CRHM) Stock?

Is CRH Medical (CRHM) a Great Value Stock Right Now?

CRH Medical Corporation: Needing Their Service And Owning Their Stock Might Make You Forget The 'Prep'

CRH Medical Corporation (CRHM) CEO Tushar Ramani on Q2 2020 Results - Earnings Call Transcript

CRH Medical Corporation (CRHM) CEO Tushar Ramani on Q1 2020 Results - Earnings Call Transcript

CRH Medical Corp. (CRHM) CEO Tushar Ramani on Q4 2019 Results - Earnings Call Transcript

Akoustis Technologies

CNX Midstream Partners

Mesoblast

Photronics

Picking breakout stocks is one of the most-favored methods for those utilizing an active investing approach since this strategy offers the promise of superlative returns.

News for Crh Medical ETF (CRHM)